These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27176482)

  • 1. Boosting clinical translation of nanomedicine.
    Jang HL; Zhang YS; Khademhosseini A
    Nanomedicine (Lond); 2016 Jun; 11(12):1495-7. PubMed ID: 27176482
    [No Abstract]   [Full Text] [Related]  

  • 2. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
    Mohammadi M; Ramezani M; Abnous K; Alibolandi M
    Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Present and the Future of Degradable Dendrimers and Derivatives in Theranostics.
    Leiro V; Garcia JP; Tomás H; Pêgo AP
    Bioconjug Chem; 2015 Jul; 26(7):1182-97. PubMed ID: 25826129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Delivery Research for the Future: Expanding the Nano Horizons and Beyond.
    Mitragotri S; Lammers T; Bae YH; Schwendeman S; De Smedt S; Leroux JC; Peer D; Kwon IC; Harashima H; Kikuchi A; Oh YK; Torchilin V; Hennink W; Hanes J; Park K
    J Control Release; 2017 Jan; 246():183-184. PubMed ID: 28110715
    [No Abstract]   [Full Text] [Related]  

  • 5. Historical perspective on advanced drug delivery: how engineering design and mathematical modeling helped the field mature.
    Peppas NA
    Adv Drug Deliv Rev; 2013 Jan; 65(1):5-9. PubMed ID: 23032270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coating microbubbles with nanoparticles for medical imaging and drug delivery.
    Tay LM; Xu C
    Nanomedicine (Lond); 2017 Jan; 12(2):91-94. PubMed ID: 27876447
    [No Abstract]   [Full Text] [Related]  

  • 7. Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview.
    Lungu II; Grumezescu AM; Volceanov A; Andronescu E
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31574993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Q&A: Omid Farokhzad on Nanomedicine in Cancer.
    Cancer Discov; 2016 Dec; 6(12):1300. PubMed ID: 27815294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prussian blue nanoparticles and their analogues for application to cancer theranostics.
    Patra CR
    Nanomedicine (Lond); 2016 Mar; 11(6):569-72. PubMed ID: 26911239
    [No Abstract]   [Full Text] [Related]  

  • 10. Click Chemistry in Biomaterials, Nanomedicine, and Drug Delivery.
    Anseth KS; Klok HA
    Biomacromolecules; 2016 Jan; 17(1):1-3. PubMed ID: 26750314
    [No Abstract]   [Full Text] [Related]  

  • 11. Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate.
    Jun YJ; Park JH; Avaji PG; Park KS; Lee KE; Lee HJ; Sohn YS
    Int J Nanomedicine; 2017; 12():5373-5386. PubMed ID: 28794629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activatable Theranostics.
    Huang P
    Curr Med Chem; 2019; 26(8):1310. PubMed ID: 31189459
    [No Abstract]   [Full Text] [Related]  

  • 13. Fully Artificial Exosomes: Towards New Theranostic Biomaterials.
    García-Manrique P; Gutiérrez G; Blanco-López MC
    Trends Biotechnol; 2018 Jan; 36(1):10-14. PubMed ID: 29074309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fundamentals of nanomedicines towards clinical translation.
    Sarmento B; Little S
    Drug Deliv Transl Res; 2020 Jun; 10(3):571. PubMed ID: 32363538
    [No Abstract]   [Full Text] [Related]  

  • 15. The drug delivery field needs a well-diversified technology portfolio.
    Park K
    J Control Release; 2017 Jan; 245():177. PubMed ID: 28065323
    [No Abstract]   [Full Text] [Related]  

  • 16. Nanodiamond-Based Theranostic Platform for Drug Delivery and Bioimaging.
    Gao G; Guo Q; Zhi J
    Small; 2019 Nov; 15(48):e1902238. PubMed ID: 31304686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfide conjugation chemistry: a mixed blessing for therapeutic drug delivery?
    Danial M; Postma A
    Ther Deliv; 2017 Jun; 8(6):359-362. PubMed ID: 28530144
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges associated and approaches for successful translation of nanomedicines into commercial products.
    Agrahari V; Hiremath P
    Nanomedicine (Lond); 2017 Apr; 12(8):819-823. PubMed ID: 28338401
    [No Abstract]   [Full Text] [Related]  

  • 19. Nanosystem composed with MSNs, gadolinium, liposome and cytotoxic peptides for tumor theranostics.
    Jin Y; Zhang N; Li C; Pu K; Ding C; Zhu Y
    Colloids Surf B Biointerfaces; 2017 Mar; 151():240-248. PubMed ID: 28024200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobiomaterials for pharmaceutical and medical applications.
    Lee H; Kim YH
    Arch Pharm Res; 2014 Jan; 37(1):1-3. PubMed ID: 24307061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.